GAL-021
GAL-021 is a potent BKCa-channel blocker. GAL-021 inhibits KCa1.1 in GH3 cells. GAL-021 is a novel breathing control modulator that is based on selective modification of the almitrine pharmacophore. GAL-021 increases minute ventilation in rats and non-human primates[1][2].
Product Specifications
CAS Number
1380341-99-0
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Potassium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/GAL-021.html
Purity
99.93
Solubility
DMSO : ≥ 30 mg/mL
Smiles
CCCNC1=NC(N(OC)C)=NC(NCCC)=N1
Molecular Formula
C11H22N6O
Molecular Weight
254.33
Precautions
H315, H319, H335
References & Citations
[1]Golder FJ, et al. Identification and Characterization of GAL-021 as a Novel Breathing Control Modulator. Anesthesiology. 2015 Nov;123 (5) :1093-104.|[2]J F McLeod, et al. GAL-021, a new intravenous BKCa-channel blocker, is well tolerated and stimulates ventilation in healthy volunteers. Br J Anaesth. 2014 Nov;113 (5) :875-83.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC610172-100 1x 100 µL
CD45 / LCA (135-4C5), CF660R conjugate, 0.1mg/mL
Sign In for Pricing
View Details